Your browser doesn't support javascript.
loading
Derivation of new pluripotent stem cells from human extended pluripotent stem cells with formative features and trophectoderm potential.
Zhu, Pinmou; Zhang, Bohang; Sun, Ruiqi; Wang, Jiachen; Liu, Zhaode; Liu, Xiaorui; Yan, Min; Cui, Yiqiang; Sha, Jiahao; Yuan, Yan.
Afiliação
  • Zhu P; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
  • Zhang B; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
  • Sun R; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
  • Wang J; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
  • Liu Z; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
  • Liu X; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
  • Yan M; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
  • Cui Y; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
  • Sha J; State Key Laboratory of Reproductive Medicine, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, China.
  • Yuan Y; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Cell Prolif ; 56(11): e13480, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37052060
ABSTRACT
Previous studies have demonstrated the existence of intermediate stem cells, which have been successfully obtained from human naive pluripotent stem cells (PSCs) and peri-implantation embryos. However, it is not known whether human extended pluripotent stem cells (hEPSCs) can be directly induced into intermediate stem cells. Moreover, the ability of extra-embryonic lineage differentiation in intermediate stem cells has not been verified. In this issue, we transformed hEPSCs into a kind of novel intermediate pluripotent stem cell resembling embryonic days 8-9 (E8-E9) epiblasts and proved its feature of formative epiblasts. We engineered hEPSCs from primed hPSCs under N2B27-LCDM (N2B27 plus Lif, CHIR, DiH and MiH) conditions. Then, we added Activin A, FGF and XAV939 to modulate signalling pathways related to early humans' embryogenesis. We performed RNA-seq and CUT&Tag analysis to compare with AF9-hPSCs from different pluripotency stages of hPSCs. Trophectoderm (TE), primordial germ cells-like cells (PGCLC) and endoderm, mesoderm, and neural ectoderm induction were conducted by specific small molecules and proteins. AF9-hPSCs transcription resembled that of E8-E9 peri-implantation epiblasts. Signalling pathway responsiveness and histone methylation further revealed their formative pluripotency. Additionally, AF9-hPSCs responded directly to primordial germ cells (PGCs) specification and three germ layer differentiation signals in vitro. Moreover, AF9-hPSCs could differentiate into the TE lineage. Therefore, AF9-hPSCs represented an E8-E9 formative pluripotency state between naïve and primed pluripotency, opening new avenues for studying human pluripotency development during embryogenesis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Pluripotentes Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Pluripotentes Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article